Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Synovial Tissue as a Biomarker to Guide Early Osteoarthritis Care

Official title: Synovial Tissue as a Biomarker in the Early Management of Osteoarthritis

Run by Nantes University Hospital · NCT07473414 · Data updated 2026-11-12

This study tests whether examining synovial tissue early in osteoarthritis can reveal biomarker pathotypes that relate to how the disease presents and progresses.

More Osteoarthritis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorNantes University Hospital
Academic / other
Locations2 sites (Nantes and 1 other locations)
StatusRecruiting
StartedMay 26, 2026
Main results expectedMay 26, 2027
Study endsMay 26, 2028
Registry record updatedJune 25, 2026
Trial IDNCT07473414 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with early osteoarthritis, who are candidates for knee intra-articular injection and can consent to biopsy.

Probably not a fit

patients with established OA or those not showing linked synovial pathotypes may not receive personalized insights from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to categorize early osteoarthritis by analyzing synovial tissue obtained during biopsy. Researchers will identify histological pathotypes in synovial samples and explore how these patterns relate to clinical features and early disease phenotypes. The protocol focuses on patients with early OA who are already being considered for knee intra-articular injection and may guide future personalized management. The study uses synovial biopsies to advance understanding of synovitis and its role in disease progression. No results are reported here; the goal is to describe the early synovial pathology and its clinical associations.

Why it matters

Potential benefit: If successful, findings could help tailor early OA treatments based on synovial tissue characteristics.

How similar studies have gone: Prior work suggests synovial pathology relates to OA phenotypes, but applying early-stage pathotypes to guide care is a newer approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of early osteoarthritis defined by the following clinical criteria:

  1. score ≤ 85% in at least two of the four categories of the KOOS questionnaire: pain, symptoms/signs, function and quality of life;
  2. presence of tenderness on palpation of the joint space or crepitus (clinical examination);
  3. Kellgren and Lawrence (KL) score of 0 or 3 (X-rays).
* Referred for therapeutic management including an intra-articular injection in the affected knee
* Patient affiliated with a social security scheme
* Patient able to understand the protocol and having signed an informed consent form.

Exclusion Criteria:

* Minors
* Adults under guardianship or trusteeship
* Pregnant women
* Breastfeeding women
* Protected patients
* Curative anticoagulation
* Thrombocytopenia \< 50,000 platelets/mm3
* Patients who object to participating in the study.

Where it's running

  • CHU de Nantes
    Nantes, France
    Recruiting
  • CHU de Nantes
    Nantes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.